BVF Partners L P/il, 10% Owner at LIGAND PHARMACEUTICALS INC (LGND), bought 14,100 shares at $13.73 ($196K) on 2011-10-18, disclosed to the SEC on 2011-10-20.
Open-market purchase of $196k LGND by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.73 | 300 | $4K | 2.1% |
| 2 | $13.73 | 500 | $7K | 3.5% |
| 3 | $13.73 | 1,400 | $19K | 9.8% |
| 4 | $13.93 | 1,600 | $22K | 11.4% |
| 5 | $13.93 | 2,700 | $38K | 19.2% |
| 6 | $13.93 | 7,600 |
| $106K |
| 54.0% |
| Total | $13.90 avg | 14,100 | $196K | 100% |
| Filing → |
| KYMR | BUY | 2022-05-31 | $8.3M | — | Filing → |
| IDYA | SELL | 2021-02-04 | $835K | — | Filing → |
| XOMA | BUY | 2020-03-27 | $284K | — | Filing → |